Phylos Bioscience has filed a notice of an exempt offering of securities to raise $4,518,519.00 in Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Phylos Bioscience is raising $4,518,519.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Dylan Anderson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Phylos Bioscience
Phylos takes the guesswork out of hemp and cannabis productionfrom popping seeds to harvest with our optimized seed-grown autoflower varieties. We believe hemp and cannabis can transform how we livefrom advancements in health and wellness, to its many potential uses in feed and fiber, to aiding in the fight against climate change. A genuine belief in the power of cannabis drives everything we do.
To learn more about Phylos Bioscience, visit http://www.phylosbioscience.com/
Contact:
Dylan Anderson, Chief Financial Officer
503-206-6599
https://www.linkedin.com/in/dylananderson/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.